British media personality Dermot Murnaghan has revealed that he has been diagnosed with stage four prostate cancer.
The 67-year-old veteran presenter has worked for the...
Merck & Co Inc said on Thursday it was launching three late-stage studies for its cancer immunotherapy Keytruda as a combination treatment for prostate cancer after the drug showed anti-tumor activity in an early-stage trial.